New Key Statistics Module, Z-Score and F-Score
NAS:BLRX Key Ratios
Market Cap $ M | 52.40 |
Enterprise Value $ M | 21.00 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.62 |
Price/Sales | 9.59 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 4.00 |
EPS (TTM) $ | -0.90 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 25.90 |
5-y EBITDA Growth Rate % | 29.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.36 |
EV-to-EBITDA | -0.37 |
PEG | -- |
Shares Outstanding M | 79.94 |
Net Margin (%) | -1,262.78 |
Operating Margin % | -895.66 |
Pre-tax Margin (%) | -1,262.81 |
Quick Ratio | 1.47 |
Current Ratio | 1.53 |
ROA % (ttm) | -94.49 |
ROE % (ttm) | -220.63 |
ROIC % (ttm) | -150.19 |
Dividend Yield % | -- |
Altman Z-Score | -10.57 |
BLRX Number of Guru Trades
BLRX Volume of Guru Trades
Gurus Latest Trades with NAS:BLRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BLRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioLine Rx Ltd Insider Transactions
No Available Data
News about NAS:BLRX
Total 0- 1